Biomerica Inc. [BMRA] shares are up more than 120.91% this year and recently decreased -0.2% or -$1.24 to settle at $6.05. BMRA has a short ratio of 1.59. This implies that the market is currently less bearish on the outlook for BMRA.
On 16, October 2020, Biomerica Reports Fiscal 2021 1st Quarter Financial Results. According to news published on Yahoo Finance, Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported financial results for the fiscal quarter ended August 31, 2020.
Analyst Birdseye View:
Before that, on January 04, 2018, B. Riley FBR Inc. Recapitulated a Buy rating and elevated its amount target to $7.50.
In the past 52 weeks of trading, this stock has oscillated between a low of $2.05 and a peak of $23.39. Right now, according to Wall Street analyst the average 12-month amount target is $12.00. At the most recent market close, shares of Biomerica Inc. [NASDAQ:BMRA] were valued at $6.05. According to the average price forecast, investors can expect a potential return of 0.0%.
Biomerica Inc. [NASDAQ:BMRA] most recently reported quarterly sales of 2.73 billion, which represented growth of 125.00%. This publicly-traded organization’s revenue is $148,727 per employee, while its income is -$51,979 per employee. This company’s Gross Margin is currently 26.60%, its Operating Margin is -35.80%, its Pretax Margin is -34.84, and its Net Margin is -34.95. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -20.79, -25.71, -24.06 and -23.67 respectively.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 11.14 and the whole liability to whole assets at 10.32. It shows enduring liability to the whole principal at 9.81 and enduring liability to assets at 0.09 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 7.13 points at 1st support level, the second support level is making up to 6.97. But as of 1st resistance point, this stock is sitting at 7.59 and at 7.89 for 2nd resistance point.
Biomerica Inc. [BMRA] reported its earnings at -$0.04 per share in the fiscal quarter closing of 5/30/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.07/share signifying the difference of 0.03 and 42.90% surprise value. Comparing the previous quarter ending of 2/28/2020, the stated earnings were -$0.09 calling estimates for -$0.06/share with the difference of -0.03 depicting the surprise of -50.00%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Biomerica Inc. [NASDAQ:BMRA] is 10.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 5.85. Now if looking for a valuation of this stock’s amount to sales ratio it’s 9.83 and it’s amount to book ratio is 5.35.
The most recent insider trade was by Sirgo Mark A, Director, and it was the sale of 5000.0 shares on Apr 21. Sirgo Mark A, the Director, completed a sale of 5000.0 shares on Apr 17.